Clinical significance of low serum magnesium in pregnant women attending the University of Benin Teaching Hospital by Enaruna, NO et al.
448 Nigerian Journal of Clinical Practice • Oct-Dec 2013 • Vol 16 • Issue 4
Abstract
Objective: Magnesium level is known to decline during pregnancy. A suggested role for magnesium deficiency in 
conditions like pre-eclampsia and pre-term birth has prompted studies with conflicting evidence. The primary objective of 
this study was to determine the prevalence of hypomagnesemia in pregnancy, while the secondary objectives attempted 
to define maternal and fetal outcome due to hypomagnesemia.
Subjects and Methods: A pilot study was performed to determine the mean serum magnesium level for the population 
of female patients attending the University of Benin Teaching Hospital. The result of the pregnant population in the pilot 
study was used as a reference for hypomagnesemia in this study. Thereafter, a prospective cohort study of antenatal 
women recruited in the second trimester and followed-up till delivery and 1 week post-partum was done. Serum 
magnesium estimates were done with samples collected at recruitment and delivery. The magnesium levels determined 
at recruitment were used to divide the subjects into two groups of hypomagnesemic and normomagnesemic patients. 
Their sociodemographic and clinical characteristics were used to generate a database for analysis.
Results: The prevalence of magnesium deficiency was 16.25%. Hypomagnesemia was significantly correlated with the 
occurrence of pre-eclampsia (P = 0.011), leg cramps (P = 0.000) and pre-term birth (P = 0.030). A logistic regression 
analysis showed that hypomagnesemia had an Odds ratio of 22 for pre-eclampsia. There was no maternal mortality 
or early neonatal death.
Conclusion: Pre-eclampsia and pre-term birth are associated with hypomagnesemia in pregnancy; hence, magnesium 
supplementation or magnesium-rich diet consisting of green leafy vegetables, soy milk and legumes may improve 
outcome.
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Introduction
Magnesium deficiency is not readily detectable as less than 
1% of the total body magnesium is found in the plasma and 
red blood cells;[1,2] moreover, ionized magnesium assays are 
non‑routine and expensive.[3] Studies from different regions 
report a decline in magnesium levels during pregnancy,[4,5] 
with values reaching their lowest point at the end of the 
first trimester.[4] Olatunbosun et al.[5] in Nigeria found an 
average serum magnesium level of 1.03 mg/dl (0.87 mEq/L) 
in the 8th month of pregnancy, dropping from a non‑pregnant 
average of 1.47 mg/dl (1.24 mEq/L).
The frequency of magnesium deficiency in pregnancy 
has been variously reported to be between 4.6% and 
48%.[6‑8] Gestational magnesium deficiency is able to induce 
maternal, fetal, neonatal and pediatric consequences, which 
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may last throughout life. Evidence from animal studies 
suggest that hypomagnesemia has marked effects on the 
processes of parturition, post‑partum uterine involution 
and fetal growth and development.[9] Many researchers 
have thus associated lack of magnesium with pre‑term 
birth, increased incidence of leg cramps and constipation 
during pregnancy,[10,11] development of pre‑eclampsia and 
fetal growth restriction,[1] as well as the sudden infant death 
syndrome.[10,12] However, the role of magnesium deficiency 
in adverse pregnancy outcome in our environment has been 
insufficiently studied.
Many studies showing that magnesium levels decline as 
pregnancy advances have also reported improvements 
in magnesium status with supplementation leading to 
significant improvements in maternal and perinatal 
outcomes.[12‑16] Magnesium intake plays a crucial role in 
magnesium status; hence, a positive magnesium balance 
can be readily achieved through supplementation or 
consumption of a magnesium‑rich diet consisting of green 
leafy vegetables, legumes and soy milk. Considering the level 
of poverty and other social deprivations in our environment, 
it is important to examine the significance of magnesium 
deficiency in pregnancy vis‑à‑vis maternal and perinatal 
health.
The frequency of magnesium deficiency in pregnancy and 
the role of hypomagnesemia in the development of adverse 
outcomes in pregnant Nigerian women are evaluated in 
this study. The findings are expected to direct attention 
to the burden of hypomagnesemia in pregnancy in our 
environment.
Materials and Methods
A prospective cohort study of patients attending antenatal 
care at the University of Benin Teaching Hospital (UBTH), 
Benin City, was conducted between June and December 2011 
with approval of the Institutional Ethics Committee. The 
subjects were healthy pregnant women with uncomplicated 
pregnancies at the time of recruitment. Peptic ulcer disease 
patients placed regularly on magnesium‑containing antacids 
and patients with multiple pregnancy, pre‑gestational 
diabetes, chronic hypertension, chronic renal disease, 
sickle cell anemia, intrauterine growth restriction, retroviral 
infection or acquired immune deficiency syndrome were 
excluded.
A pilot study involving both pregnant and non‑pregnant 
women attending the outpatient clinic in UBTH found the 
mean serum magnesium level of the pregnant population to 
be 2.01 ± 0.49 mEq/L. Thus, in this study, hypomagnesemia 
was defined as serum magnesium level lower than (the 
mean −2	SD),	i.e.,	1.03	mEq/L.
The sample size was calculated[17] based on a previous 
study that reported 43.6%[7] hypomagnesemia in the rural 
pregnant Indian population. We aimed at detecting a 50% 
decrease in pregnant Nigerian women in the current study, 
who were largely urban dwellers. Accepting a statistical 
power of 80% and confidence interval of 90%, with the level 
of significance set at 0.05, and up to 10% of the participants 
expected to drop out, a sample size of 160 patients was 
obtained.
All patients who met the inclusion criteria were recruited 
after obtaining an informed written consent. Due counseling 
on the nature of the study, the quantity of blood to be taken, 
the details of the subsequent follow‑up, and the time of 
termination of the study for each patient was given. The 
eligible patients had their venous blood taken for serum 
magnesium measurement at recruitment. Subsequently, 
they were followed‑up till delivery, when a repeat serum 
magnesium assay was done, and to discharge from hospital 
or up to 1 week post‑delivery if they stayed longer on 
admission.
Five milliliters of venous blood was taken from each 
patient in the antenatal side laboratory at recruitment 
and subsequently in the labor ward at delivery for assay 
of serum magnesium. The blood was collected in a 20‑ml 
plain plastic container and immediately transferred to the 
clinical chemistry laboratory where serum was separated 
by centrifugation at 2000 rpm following clot retraction. 
The	 separated	 serum	was	 then	 frozen	 at	−80°C	 until	
the time for analysis. Analysis was done by a direct 
measurement (Calmagite method) in the clinical chemistry 
laboratory using the kit manufactured by Teco Diagnostics, 
California, USA, which defines the adult reference range 
as 1.3‑2.5 mEq/L.[18]
The primary outcome measure was the prevalence of 
hypomagnesemia in pregnancy. The hypomagnesemic and 
normomagnesemic groups were also compared for maternal 
and perinatal clinical outcome. Evaluation of the patients 
commenced between 24 and 26 weeks gestation. The 
participants were told to take only the routine hematinics 
given to them in the clinic. All complications in pregnancy 
and outcome of delivery were then noted. In particular, 
the patients were assessed for occurrence of leg cramps in 
pregnancy; after delivery, the presence of and need to treat 
uterine cramps were evaluated. Following delivery, the 
mothers were followed‑up in the lying‑in ward along with 
their babies. For the babies admitted to the special care baby 
unit (SCBU), their follow‑up was done in conjunction with 
the neonatologists.
For all participants, sociodemographic data including age, 
parity, occupation and level of education of the patient and 
her spouse, estimated gestational age, as well as relevant 
clinical parameters were entered into a proforma, and the 
information was used to generate a database. The social 
Enaruna, et al.: Hypomagnesemia and adverse pregnancy outcome in Benin City
450 Nigerian Journal of Clinical Practice • Oct-Dec 2013 • Vol 16 • Issue 4
classes of the women were determined using the Olusanya 
et al.[19] classification, making use of the educational status 
of the woman and her husband’s occupation.
The subjects were divided into two groups at the end of 
the study depending on the determination of their serum 
magnesium levels at recruitment. The study thus comprised: 
Group A with those who had serum magnesium levels 
less than two standard deviations (SD) below the mean 
of the pilot study; and Group B were patients with serum 
magnesium levels from two SD below the mean to above 
the mean.
Statistical analysis was done with a personal computer using 
the SPSS (SPSS Inc., Chicago Ill, 2006) for Windows 
version 15.0 and GraphPad InStat 3 softwares. Categorical 
variables were expressed as absolute numbers and percentages 
and significant differences were determined using the 
Chi square test or fisher exact test where appropriate, while 
continuous variables were presented as means with SDs and 
significant differences being determined with the Student t 
test. The level of significance was set as P < 0.05.
Results
The mean serum magnesium level at recruitment was 
1.54 ± 0.46 mEq/L, and at delivery it was 1.37 ± 0.45 mEq/L 
(P = 0.001). The prevalence of hypomagnesemia was 8% 
higher at delivery than at recruitment (25% vs. 16.25%; 
P  = 0.072, Table 1). The teenage mothers were 5‑times 
more likely to have hypomagnesemia than women 20 years 
or older (100% vs. 20.75%, P  = 0.001; Table 2). The 
risk of having hypomagnesemia in women of parity four 
was almost twice that of the nulliparas, but this did not 
reach statistical significance (30% vs. 16.7%, P = 0.381; 
Table 2). Social Class 4 was almost 5‑times more likely to 
be associated with hypomagnesemia than Social Class 1 
(100% vs. 23%, P = 0.000; Table 2).
The development of pre‑eclampsia was 24% higher in the 
hypomagnesemic group than in the normomagnesemic 
group (38.5% vs. 14.9%, P = 0.011; Table 3). There were no 
cases of glucose intolerance in this study. Intrauterine fetal 
death was not encountered in this study. Symphysiofundal 
height smaller than date found at the time of delivery was 
associated with low serum magnesium levels in 5.3% of the 
subjects compared with 94.7% in the normomagnesemic 
group. The incidence of pre‑term birth was generally 
low in this study. All the subjects in this study delivered 
after 34 weeks of gestation. However, pre‑term birth was 
19% more likely in women with low serum magnesium 
than in normomagnesemic subjects (30.8% vs. 11.9%, 
P = 0.030; Table 3). Similarly, the occurrence of leg cramps 
was 44% higher in the hypomagnesemic group than in patients 
who had normal serum magnesium levels (69% vs. 25%, 
P = 0.000; Table 3). Post‑partum uterine cramps were reported 
by 16% more patients with normal magnesium levels than 
the hypomagnesemic group (24% vs. 8%, P = 0.071; Table 3). 
There was no maternal mortality in the study population.
A logistic regression analysis was conducted to predict the 
roles of age, parity, social class and body mass index (BMI) as 
confounding variables in the determination of pre‑eclampsia, 
pre‑term birth and leg cramps by hypomagnesemia. A test 
of the full model was statistically significant for all three 
dependent variables (Chi square 43.478, P = 0.000, with 
df  = 5; Chi square 51.419, P  = 0.000, with df  = 5; and 
Chi square 30.407, P = 0.000, with df = 5, respectively). 
Prediction success overall for pre‑eclampsia, pre‑term birth 
and leg cramps was 87.8%, 87.1% and 74.8%, respectively. 
A test of age, parity, social class and BMI to predict 




Gp A (n=26) 
frequency (%)
Gp B (n=134) 
frequency (%)
P value
Enrollment 26 (16.25) 134 (83.75) 0.072
Delivery 40 (25) 120 (75)
Values are given as number (percent), Gp= Group
Table 2: Maternal socio‑demographic characteristics in 
relation to hypomagnesaemia
Characteristic Frequency (%) P value
Gp A (n=26) Gp B (n=134)
Age (years)
<20 4 (15.38) 0 (0) 0.000
20‑35 8 (30.77) 82 (61.19)
>35 14 (53.85) 52 (38.81)
Parity
0 8 (30.77) 40 (29.85) 0.455
1‑3 15 (57.69) 87 (64.93)
≥4 3 (11.54) 7 (5.22)
Body mass index kg/m2
Normal 10 (38.47) 36 (26.87) 0.015
Overweight 16 (61.53) 64 (47.76)
Obese 0 (0) 34 (25.37)
Social class
1 18 (69.23) 60 (44.78) 0.000
2 0 (0) 42 (31.34)
3 0 (0) 32 (23.88)
4 8 (30.77) 0 (0)
Gp= Group
Table 3: Adverse maternal outcome
Variable Gp A (n=26) 
frequency (%)
Gp B (n=134) 
frequency (%)
P value
Preeclampsia 10 (38.46) 20 (14.93) 0.011
Leg cramps 18 (69.23) 34 (25.37) 0.000
Preterm birth 8 (30.77) 16 (11.94) 0.030 
Postpartum cramps 2 (7.69) 32 (23.88) 0.071
Values are given as number (percent), Gp= Group
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hypomagnesemia showed that only age was statistically 
significant (P = 0.042).
The Wald criterion demonstrated that age, BMI and 
hypomagnesemia made significant contributions to 
prediction of pre‑eclampsia; age, parity and hypomagnesemia 
to pre‑term birth; and only age contributed significantly to 
leg cramps, although hypomagnesemia and social class were 
significant in the “variables not in equation” table (P = 0.046 
and P = 0.000, respectively). Hypomagnesemia was 22‑times 
more likely to contribute to the occurrence of pre‑eclampsia 
than age [Table 4].
Adverse perinatal events were generally few in this study. 
There were 12 cases of low birth weight babies, with 2 (7.7%) 
of them born to mothers who had low magnesium levels, but 
this did not reach statistical significance (P = 1.000). Birth 
asphyxia occurred 3% higher in the 26 babies born to women 
with hypomagnesemia than 134 babies of normomagnesemic 
mothers (15% vs. 12%, P = 0.745; Table 5). All eight babies 
admitted to the SCBU for moderate birth asphyxia were 
born to women in the normomagnesemic group (P = 0.356), 
and were transferred to their mothers within 96 h of 
admission. There was no early neonatal death; all the babies 
were either discharged or were alive at the termination of 
the study 7th day post‑partum.
Discussion
This study revealed that 16.25% of our pregnant women 
had deficiency of magnesium. Young age was associated 
with magnesium deficiency. Magnesium deficiency was 
also observed to increase the likelihood of pre‑eclampsia 
and pre‑term birth.
The previous pilot study and the prospective design of this 
study were essential in the validity of our results. The sample 
size of 160 pregnant women was adequate, although it was 
smaller than some previous study populations.[5,7] This was 
a tertiary hospital‑based study in an urban setting; even 
so, its results may be representative of the general patient 
population because of the referral status of the hospital. The 
direct (Calmigite) measurement of serum magnesium used 
in this study has been shown to have acceptable precision 
and coefficient of variation.[17]
Our study confirmed the finding of previous workers that 
serum magnesium values are reduced during pregnancy.[10,11] 
Suggested reasons for the low levels of magnesium in 
pregnancy include inadequate intake, increased metabolic 
demand of pregnancy, especially as gestation advance, 
physiological hemodilution in pregnancy, and increasing 
parity.[1,7] Our observed hypomagnesemia prevalence 
of 16.25% is lower than the figures reported by some 
investigators working in different populations. Pathak et al.[7] 
reported an incidence of 43.6% among rural Indian women 
in a community‑based cross‑sectional study, and showed 
that higher parity was associated with higher rates of lack of 
magnesium. Kumar and co‑authors[8] found a prevalence of 
48% in their study, but failed to show any difference between 
urban and rural participants, nor did they find any association 
between hypomagnesemia and social class. However, 
Kapil et al.[6] studied urban Indian dwellers and reported 
magnesium deficiency in only 4.6% of all pregnant women 
included in the study. Our finding that teenagers had a higher 
prevalence of hypomagnesemia has also been reflected in a 
previous study.[7] This is likely a result of higher demands of 
pregnancy at an age characteristic for poor nutrition.
Similar to this study, several investigators in the past have 
also reported a link between magnesium depletion and 
hypertension in pregnancy from both animal and human 
studies.[20‑23] This link is attributed to vascular muscle 
spasm in the uterus, which is thought to be produced by 
magnesium deficiency.[1] Standley et al.[24] in their study 
demonstrated that all subjects who eventually developed 
pre‑eclampsia showed a decrease in ionized magnesium 
concentration with increasing gestational age. In this study, 
there were 10 patients with hypomagnesemia at recruitment 
who developed pre‑eclampsia. Another 10 patients 
who had normal magnesium levels at recruitment and 
eventually developed pre‑eclampsia were found to have 
low serum magnesium levels at delivery. The remaining 
10 pre‑eclamptics had normal serum magnesium levels 
at delivery; however, their sub‑group analysis revealed a 
decrease from a mean of 1.41 ± 0.41 mEq/L at recruitment 
to 1.22 ± 0.08 mEq/L at delivery, and this was in agreement 
with the report of Standley et al.[24] In our study, further 
logistic regression also showed that hypomagnesemia was 
22‑ and 47‑times more likely to result in pre‑eclampsia than 
age or BMI, respectively.
Table 4: Logistic regression tables for preeclampsia, 
preterm birth and leg cramps
Variable P value
Preeclampsia Preterm birth Leg cramps
Age 0.003 0.132 0.000
Parity 0.227 0.006 0.692
BMI 0.001 0.034 0.812
Social class 0.999 0.999 0.998
Hypomagnesaemia 0.000 0.000 0.268
Constant 0.763 0.147 0.000
BMI=Body mass index
Table 5: Adverse perinatal outcome
Characteristic Gp A (n=26) 
frequency (%)
Gp B (n=134) 
frequency (%)
P value
Low birth weight 2 (7.69) 10 (7.46) 1.000
Birth asphyxia 4 (15.38) 16 (11.94) 0.745
SCBU admission 0 (0) 8 (5.97) 0.356
Values are given as number (percent), SCBU=Special care baby unit, Gp= 
Group
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The association of leg cramps with low serum magnesium 
in this study supports the finding by Dahle et al.[25] in 
a prospective double‑blind, randomized trial that oral 
magnesium substitution was associated with a significant 
decrease in leg cramps distress. Similarly, a Cochrane review 
by Young and Jewell[26] provided evidence for magnesium 
lactate or citrate in the treatment of muscle cramps in 
pregnancy.
The role of magnesium lack in pre‑term birth has been 
documented previously by Shahid et al.,[27] who concluded 
that this observation can be useful as a marker for pre‑term 
delivery. Our study also found a significant association of low 
serum magnesium and pre‑term birth. A possible mechanism 
of action of magnesium in pre‑term labor attenuation is by 
competing with intracellular calcium at its binding sites, 
thereby decreasing muscle contractility and stabilizing the 
membrane potential. Other authors have reported improved 
outcome in patients given magnesium supplements, with 
evidence of reduced pre‑term births.[10,11]
Symphysiofundal height discrepancy during pregnancy, 
which may be suggestive of intrauterine growth restriction, 
was not associated with magnesium deficiency in this study. 
A few researchers have, however, linked poor fetal growth 
with gestational magnesium deficiency.[12,14] It is possible that 
ultrasound diagnosis of intrauterine growth restriction may 
be a better parameter to analyze with respect to magnesium 
deficiency than symphysiofundal height measurement.
The literature suggests a possible role for magnesium deficiency 
in the causation of post‑partum uterine cramps.[11] In contrast, 
our findings in the present study did not show any correlation 
between the lack of magnesium and the occurrence of 
post‑partum uterine cramps. This may be so because those 
studies reporting an association were interventional and 
involved the use of supplemental magnesium salts without 
a documentation of deficiency. This makes it difficult to 
determine what level of deficiency is critical for uterine cramps 
to be significant. It is also possible that other factors may be 
involved in the determination of what the patient considers 
to be significant uterine cramps necessitating reporting, such 
as previous experience during breastfeeding, parity, age, mode 
of delivery, and emotional state.
With respect to perinatal outcome, the findings of this 
study did not show any relationship between the lack of 
magnesium and the rates of low birth weight, birth asphyxia, 
or SCBU admission, contrary to the reports of some other 
workers.[9,12‑14] However, the findings in the present study 
are not surprising considering the fact that most babies were 
delivered after the 34th week of gestation and therefore, 
perinatal outcome was expected to be favorable.
A factor in the pregnant woman that may suggest lack 
of magnesium was shown in this study to be young age. 
The relationship of a negative magnesium balance to the risk 
of pre‑eclampsia and pre‑term delivery was confirmed in this 
study. It is noteworthy that the toll on maternal health and 
perinatal indices from a combination of pre‑eclampsia and 
pre‑term delivery remains significant in our environment.
To reduce the high prevalence of magnesium deficiency 
in pregnancy, magnesium balance needs to be improved. 
This can be attained through nutritional counseling. We 
recommend that the average diet in this environment be 
evaluated in a nutritional survey to determine the content 
of magnesium. The diet with the highest amounts of 
magnesium can be advised for women who are at risk of 
magnesium deficiency. We also recommend interventional 
studies to prove the efficacy or otherwise of dietary 
counseling or magnesium substitution in pregnancy 
involving these high‑risk groups in a case‑control study.
In conclusion, discouraging teenage pregnancy and 
improving the socio‑economic status of every woman 
through education and social emancipation will directly 
translate to giving them the means to better their 
magnesium balance in or out of pregnancy. Magnesium 
supplementation or consumption of a magnesium‑rich diet 
should be recommended in pregnancy.
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